Thermo Fisher Scientific’s (TMO) Outperform Rating Reaffirmed at Robert W. Baird

Thermo Fisher Scientific (NYSE:TMO – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Robert W. Baird in a research report issued on Thursday, Benzinga reports. They currently have a $670.00 price target on the medical research company’s stock. Robert W. Baird’s target price would indicate a potential upside of […]

Leave a Reply

Your email address will not be published.

Previous post Ouster, Inc. (NYSE:OUST) CFO Mark Weinswig Sells 2,462 Shares of Stock
Next post FedEx Co. (NYSE:FDX) Shares Bought by Salem Investment Counselors Inc.